Validation of an MRI Brain Injury and Growth Scoring System in Very Preterm Infants Scanned at 29- to 35-Week

J M George1, S Fiori2, J Fripp3

  • 1From the Queensland Cerebral Palsy and Rehabilitation Research Centre (J.M.G., R.N.B.), Centre for Children's Health Research, Faculty of Medicine j.george2@uq.edu.au.

Insights

A new brain MR imaging scoring system, used between 29-35 weeks postmenstrual age, effectively predicts neurodevelopmental outcomes in very preterm infants. This tool identifies at-risk infants earlier than current methods.

Area of Science:

  • Neonatal neuroimaging
  • Developmental neuroscience
  • Pediatric neurology

Background:

  • Early brain magnetic resonance (MR) imaging in preterm infants is crucial for diagnosis and prognosis.
  • Existing MR imaging scoring systems have limitations for early assessment before term-equivalent age.

Purpose of the Study:

  • To validate a novel MR imaging scoring system for brain injury and impaired growth.
  • To assess the system's utility between 29 to 35 weeks postmenstrual age in infants born before 31 weeks gestational age.

Main Methods:

  • Prospective cohort study of 83 preterm infants (<31 weeks gestational age).
  • Early 3T MR imaging (29-35 weeks PMA) and follow-up MR imaging at term-equivalent age.
  • Scoring of brain structures (WM, gray matter, cerebellum, global) and correlation with 12-month corrected age neurodevelopmental assessments (Bayley III, NSMDA).

Main Results:

  • Early MR imaging global, white matter (WM), and deep gray matter scores correlated negatively with motor and cognitive outcomes (Bayley III) and NSMDA.
  • Early cerebellar scores were negatively associated with NSMDA outcomes.
  • Findings were consistent with term-equivalent-age MR imaging.

Conclusions:

  • A clinically accessible MR imaging scoring system is validated for early use (29-35 weeks PMA) in very preterm infants.
  • This system enables early identification of infants at risk for adverse neurodevelopmental outcomes.
  • The scoring system offers prognostic potential before the standard term-equivalent age assessment.
Abstract

Related Concept Videos